{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:17:37Z","timestamp":1783048657431,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Orbital exenteration is a radical procedure used in selected orbital malignancies, yet survival outcomes vary widely, particularly in recurrent or previously treated disease. We evaluated the association of pathological stage (nodal and\/or distant metastasis status) and margin status with overall survival (OS) and disease-free survival (DFS) in patients undergoing exenteration for recurrent or previously treated orbital cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 39 patients who underwent orbital exenteration between 2017 and 2024. Patients were categorized as localized disease (pN0\/pM0) or advanced disease with nodal and\/or distant metastasis (pN\u2009+\u2009and\/or pM+). Survival was estimated using Kaplan\u2013Meier analysis and compared using the log-rank test. Median follow-up was 365 days. Margins were classified as R0 or R1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 39 patients, 24 (61.5%) had localized disease and 15 (38.5%) had advanced disease with nodal and\/or distant metastasis; 6 patients (15.4%) had positive margins. 24-month OS was 78% in localized disease versus 33% in patients with nodal and\/or distant metastasis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011). Median OS was not reached in localized disease and was 13 months in patients with nodal and\/or distant metastasis. 24-month DFS was 62.5% versus 33% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017). R1 margins were associated with markedly worse outcomes: 24-month OS 0% vs. 75.8% for R0, and all R1 patients recurred within 12 months. Sensitivity analysis excluding\u2009&lt;\u20096-month follow-up confirmed these findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nodal and\/or distant metastatic status and positive surgical margins were associated with worse survival outcomes after orbital exenteration for recurrent or previously treated orbital malignancies. Most adverse events occurred within the first postoperative year, suggesting a clinically relevant early risk period. Given the histological heterogeneity of the cohort, these findings should be interpreted as prognostic patterns in a salvage orbital oncology population and require validation in larger disease-specific series.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10006-026-01591-z","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:35:03Z","timestamp":1783046103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival outcomes after orbital exenteration for recurrent or previously treated orbital malignancies: impact of margin status and metastatic spread"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-3667","authenticated-orcid":false,"given":"M.","family":"Todaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2602-5074","authenticated-orcid":false,"given":"F.","family":"Perquoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1965-5226","authenticated-orcid":false,"given":"F.","family":"De Lorenzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5091-5178","authenticated-orcid":false,"given":"G.","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9760-2419","authenticated-orcid":false,"given":"G.","family":"Saponaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-0500","authenticated-orcid":false,"given":"G.","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9993-5986","authenticated-orcid":false,"given":"G.","family":"Savino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Sammarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Pagliara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5492-8371","authenticated-orcid":false,"given":"G.","family":"Schinzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"L.","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fionda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-1505","authenticated-orcid":false,"given":"F.","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-4078","authenticated-orcid":false,"given":"T.","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Ausili","family":"Cefaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4164-0781","authenticated-orcid":false,"given":"X. Moix","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3450-2534","authenticated-orcid":false,"given":"V.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-171X","authenticated-orcid":false,"given":"A.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"1591_CR1","volume-title":"Ophthalmodoulcia\u2014That Is Service of the Eyes","author":"G Bartisch","year":"2018","unstructured":"Bartisch G (2018) Ophthalmodoulcia\u2014That Is Service of the Eyes. Wayenborgh Publishing, Belgium"},{"key":"1591_CR2","first-page":"413","volume":"141","author":"SS Golovine","year":"1909","unstructured":"Golovine SS (1909) Orbito-sinus exenteration. Ann Ocul 141:413\u2013431","journal-title":"Ann Ocul"},{"key":"1591_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jcms.2017.01.003","volume":"45","author":"MR Kesting","year":"2017","unstructured":"Kesting MR, Koerdt S, Rommel N, M\u00fccke T, Wolff KD, Nobis CP, Ringel F, Frohwitter G (2017) Classification of orbital exenteration and reconstruction. J Craniomaxillofac Surg 45:467\u2013473. https:\/\/doi.org\/10.1016\/j.jcms.2017.01.003","journal-title":"J Craniomaxillofac Surg"},{"key":"1591_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcms.2020.05.008","volume":"49","author":"SH Baum","year":"2021","unstructured":"Baum SH, Schmeling C, Eckstein A, Mohr C (2021) Orbital exenteration: symptoms, indications, tumor localizations, pathologies, reconstruction, complications and survival. J Craniomaxillofac Surg 49:659\u2013669. https:\/\/doi.org\/10.1016\/j.jcms.2020.05.008","journal-title":"J Craniomaxillofac Surg"},{"key":"1591_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174285","volume":"15","author":"J Qedair","year":"2023","unstructured":"Qedair J, Haider AS, Balasubramanian K et al (2023) Orbital exenteration for craniofacial lesions: a systematic review and meta-analysis of patient characteristics and survival outcomes. Cancers 15:4285. https:\/\/doi.org\/10.3390\/cancers15174285","journal-title":"Cancers"},{"key":"1591_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jfma.2020.10.030","volume":"120","author":"WY Wang","year":"2021","unstructured":"Wang WY, Liao SL, Wei YH (2021) Orbital exenteration: a 20-year experience from a tertiary center in Taiwan. J Formos Med Assoc 120:1493\u20131499. https:\/\/doi.org\/10.1016\/j.jfma.2020.10.030","journal-title":"J Formos Med Assoc"},{"key":"1591_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bjps.2025.03.060","volume":"105","author":"P Niinim\u00e4ki","year":"2025","unstructured":"Niinim\u00e4ki P, M\u00e4\u00e4tt\u00e4nen M, Vuola J, Kivel\u00e4 TT, M\u00e4kitie AA, Uusitalo M (2025) Orbital exenteration in the management of orbital and periorbital tumours: factors related to treatment outcomes. J Plast Reconstr Aesthet Surg 105:260\u2013269. https:\/\/doi.org\/10.1016\/j.bjps.2025.03.060","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"1591_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/jcm13030726","volume":"13","author":"K G\u0105siorowski","year":"2024","unstructured":"G\u0105siorowski K, Gontarz M, Marecik T et al (2024) Risk Factors for Orbital Invasion in Malignant Eyelid Tumors: Is Orbital Exenteration Still Necessary? J Clin Med 13:726. https:\/\/doi.org\/10.3390\/jcm13030726","journal-title":"J Clin Med"},{"key":"1591_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jfo.2019.09.011","volume":"43","author":"A Martel","year":"2019","unstructured":"Martel A, Hamedani M, Lagier J, Bertolotto C, Gastaud L, Poissonnet G (2019) L\u2019exent\u00e9ration orbitaire a-t-elle encore sa place en 2019? J Fr Ophtalmol 43:152\u2013174. https:\/\/doi.org\/10.1016\/j.jfo.2019.09.011","journal-title":"J Fr Ophtalmol"},{"key":"1591_CR10","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/hed.27401","volume":"45","author":"K Sun","year":"2023","unstructured":"Sun K, Tan JY, Thomson PJ, Choi SW (2023) Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: a systematic review. Head Neck 45:2108\u20132119. https:\/\/doi.org\/10.1002\/hed.27401","journal-title":"Head Neck"},{"key":"1591_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/SAP.0b013e31828bb582","volume":"74","author":"A Torroni","year":"2015","unstructured":"Torroni A, Cervelli D, Gasparini G, Grussu F, Moro A, Marianetti TM, Foresta E, Azzuni C, Pelo S (2015) Anterior retrograde approach to the myofascial temporalis muscle for orbital reconstruction: series of 9 consecutive cases. Ann Plast Surg 74:37\u201342. https:\/\/doi.org\/10.1097\/SAP.0b013e31828bb582","journal-title":"Ann Plast Surg"},{"key":"1591_CR12","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1245\/s10434-024-16854-w","volume":"32","author":"A Murray-Douglass","year":"2025","unstructured":"Murray-Douglass A, Crawford L, Hunt J et al (2025) Survival after orbital exenteration for primary cutaneous squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol 32:2725\u20132731. https:\/\/doi.org\/10.1245\/s10434-024-16854-w","journal-title":"Ann Surg Oncol"},{"key":"1591_CR13","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/cncr.25813","volume":"117","author":"HD Skinner","year":"2011","unstructured":"Skinner HD, Garden AS, Rosenthal DI et al (2011) Outcomes of Malignant Tumors of the Lacrimal Apparatus: The University of Texas MD Anderson Cancer Center Experience. Cancer 117:2801\u20132810. https:\/\/doi.org\/10.1002\/cncr.25813","journal-title":"Cancer"},{"key":"1591_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/IOP.0b013e31818be098","volume":"24","author":"A Hsu","year":"2008","unstructured":"Hsu A, Frank SJ, Ballo MT et al (2008) Postoperative Adjuvant External-Beam Radiation Therapy for Cancers of the Eyelid and Conjunctiva. Ophthalmic Plast Reconstr Surg 24:444\u2013449. https:\/\/doi.org\/10.1097\/IOP.0b013e31818be098","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1591_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/bjophthalmol-2017-310681","volume":"102","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Ho S, Yin V et al (2018) Multicentered international review of orbital exenteration and reconstruction in oculoplastic and orbit practice. Br J Ophthalmol 102:654\u2013658. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310681","journal-title":"Br J Ophthalmol"},{"key":"1591_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamaoto.2022.5186","volume":"149","author":"PR Sunkara","year":"2023","unstructured":"Sunkara PR, Graff JT, Cramer JD (2023) Association of surgical margin distance with survival in patients with resected head and neck squamous cell carcinoma: a secondary analysis of a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 149:317\u2013326. https:\/\/doi.org\/10.1001\/jamaoto.2022.5186","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1591_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010094","volume":"14","author":"P Palmisciano","year":"2021","unstructured":"Palmisciano P, Ferini G, Ogasawara C et al (2021) Orbital metastases: a systematic review of clinical characteristics, management strategies, and treatment outcomes. Cancers 14:94. https:\/\/doi.org\/10.3390\/cancers14010094","journal-title":"Cancers"},{"key":"1591_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0850-y","volume":"18","author":"O Aryasit","year":"2018","unstructured":"Aryasit O, Preechawai P, Hirunpat C et al (2018) Factors related to survival outcomes following orbital exenteration: a retrospective, comparative case series. BMC Ophthalmol 18:186. https:\/\/doi.org\/10.1186\/s12886-018-0850-y","journal-title":"BMC Ophthalmol"},{"key":"1591_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4314\/ejhs.v26i6.6","volume":"26","author":"L Ben","year":"2016","unstructured":"Ben L, Aemero M, Gushchin AG, Moore GH, Rohit S (2016) Clinico-pathological patterns of patients who underwent orbital exenteration in a tertiary eye hospital of Nepal. Ethiop J Health Sci 26:543\u2013548. https:\/\/doi.org\/10.4314\/ejhs.v26i6.6","journal-title":"Ethiop J Health Sci"},{"key":"1591_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/IOP.0000000000002137","volume":"38","author":"M Malik","year":"2022","unstructured":"Malik M, Vahdani K, Rose GE et al (2022) Orbital Exenteration for Advanced Periocular Adnexal Malignancies: Curative versus Palliative Surgical Intent. Ophthalmic Plast Reconstr Surg 38:387\u2013392. https:\/\/doi.org\/10.1097\/IOP.0000000000002137","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-026-01591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-026-01591-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-026-01591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:35:05Z","timestamp":1783046105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-026-01591-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s10006-026-01591-z","relation":{},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the institutional policy of Fondazione Policlinico Universitario A. Gemelli IRCCS for retrospective observational studies using fully anonymized data collected as part of routine clinical care, formal ethics committee approval was not required. No additional interventions were performed for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"105"}}